Clene (CLNN) EBITDA Margin (2020 - 2026)
Clene's EBITDA Margin was -5548.89% in Q2 2026, up 14947.41 percentage points from -20496.30% a year earlier.
Powered by 
Analysis
Clene (CLNN) EBITDA Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Clene's EBITDA Margin was -10981.34% through Jun 30, 2026, down 2276.44 percentage points year-over-year; for FY2025, it came in at -10802.50%, down 1605.13 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -1457.35 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was -9197.37% in FY2024 (-3259.30 pp), -5938.07% in FY2023 (+4080.95 pp), -10019.03% in FY2022 (-3235.49 pp) and -6783.54% in FY2021 (+2561.60 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin since Q1 2025.
- Compared with a year earlier, EBITDA Margin was higher in two of the last seven quarters, with an average year-over-year change of -2976.40 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q2 2023 (a gain of 34359.08 percentage points); the worst was Q1 2022 (a drop of 38424.93 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Clene | 52.14 Mn | 52.14 Mn | 54,000.00 | -5,548.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -5,548.89% |
| Dec 31, 2025 | -9,272.73% |
| Sep 30, 2025 | -35,220.00% |
| Jun 30, 2025 | -20,496.30% |
| Mar 31, 2025 | -4,562.96% |
| Dec 31, 2024 | -9,073.63% |
| Sep 30, 2024 | -8,516.09% |
| Jun 30, 2024 | -7,676.92% |
| Mar 31, 2024 | -12,071.23% |
| Dec 31, 2023 | -5,592.94% |
| Sep 30, 2023 | -8,428.70% |
| Jun 30, 2023 | -3,678.07% |
| Mar 31, 2023 | -9,654.21% |
| Dec 31, 2022 | -4,858.55% |
| Sep 30, 2022 | -5,501.15% |
| Jun 30, 2022 | -38,037.14% |
| Mar 31, 2022 | -43,803.33% |
| Dec 31, 2021 | -6,964.32% |
| Sep 30, 2021 | -9,331.82% |
| Jun 30, 2021 | -6,738.81% |
API Access
Clene EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CLNN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CLNN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CLNN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();